Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues. The company’s stock gained during Thursday’s after-hours trading session, following the announcement.
The Canada-based medical marijuana company said its net loss narrowed to C$137.39 million or C$1.37 per share in the March-quarter from C$158.35 million or C$1.89 per share in the same period of last year. The improvement in the bottom-line performance reflects a 16% increase in revenues to C$75.52 million.
Shares of Aurora Cannabis closed Thursday’s regular session higher in the New York Stock Exchange and continued to gain during the extended trading session. The stock, which has been on a downward spiral for several months, lost 73% since the beginning of the year.
Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a
PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the
With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,